This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An author's correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quenelle, D. C.
Right arrow Articles by Kern, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quenelle, D. C.
Right arrow Articles by Kern, E. R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2004, p. 404-412, Vol. 48, No. 2
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.2.404-412.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Oral Treatment of Cowpox and Vaccinia Virus Infections in Mice with Ether Lipid Esters of Cidofovir

Debra C. Quenelle,1 Deborah J. Collins,1 W. Brad Wan,2 James R. Beadle,2 Karl Y. Hostetler,2 and Earl R. Kern1*

The University of Alabama School of Medicine, Birmingham, Alabama,1 The San Diego Veterans Affairs Healthcare System and the University of California, San Diego, La Jolla, California2

Received 7 July 2003/ Returned for modification 23 September 2003/ Accepted 7 October 2003

Four newly synthesized ether lipid esters of cidofovir (CDV), hexadecyloxypropyl-CDV (HDP-CDV), octadecyloxyethyl-CDV (ODE-CDV), oleyloxypropyl-CDV (OLP-CDV), and oleyloxyethyl-CDV (OLE-CDV), were found to have enhanced activities against vaccinia virus (VV) and cowpox virus (CV) in vitro compared to those of CDV. The compounds were administered orally and were evaluated for their efficacies against lethal CV or VV infections in mice. HDP-CDV, ODE-CDV, and OLE-CDV were effective at preventing mortality from CV infection when treatments were initiated 24 h after viral inoculation, but only HDP-CDV and ODE-CDV maintained efficacy when treatments were initiated as late as 72 h postinfection. Oral pretreatment with HDP-CDV and ODE-CDV were also effective when they were given 5, 3, or 1 day prior to inoculation with CV, even when each compound was administered as a single dose. Both HDP-CDV and ODE-CDV were also effective against VV infections when they were administered orally 24 or 48 h after infection. In animals treated with HDP-CDV or ODE-CDV, the titers of both CV and VV in the liver, spleen, and kidney were reduced 3 to 7 log10. In contrast, virus replication in the lungs was not significantly reduced. These data indicate that HDP-CDV or ODE-CDV given orally is as effective as CDV given parenterally for the treatment of experimental CV and VV infections and suggest that these compounds may be useful for the treatment of orthopoxvirus infections in humans.

* Corresponding author. Mailing address: Department of Pediatrics, The University of Alabama at Birmingham, 128 Children's Harbor Building, 1600 6th Ave. South, Birmingham, AL 35233. Phone: (205) 934-1990. Fax (205) 975-1992. E-mail: Kern{at}uab.edu.

Antimicrobial Agents and Chemotherapy, February 2004, p. 404-412, Vol. 48, No. 2
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.2.404-412.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Kern, E. R., Prichard, M. N., Quenelle, D. C., Keith, K. A., Tiwari, K. N., Maddry, J. A., Secrist, J. A. III (2009). Activities of Certain 5-Substituted 4'-Thiopyrimidine Nucleosides against Orthopoxvirus Infections. Antimicrob. Agents Chemother. 53: 572-579 [Abstract] [Full Text]  
  • McSharry, J. J., Deziel, M. R., Zager, K., Weng, Q., Drusano, G. L. (2009). Pharmacodynamics of Cidofovir for Vaccinia Virus Infection in an In Vitro Hollow-Fiber Infection Model System. Antimicrob. Agents Chemother. 53: 129-135 [Abstract] [Full Text]  
  • Gammon, D. B., Snoeck, R., Fiten, P., Krecmerova, M., Holy, A., De Clercq, E., Opdenakker, G., Evans, D. H., Andrei, G. (2008). Mechanism of Antiviral Drug Resistance of Vaccinia Virus: Identification of Residues in the Viral DNA Polymerase Conferring Differential Resistance to Antipoxvirus Drugs. J. Virol. 82: 12520-12534 [Abstract] [Full Text]  
  • Toth, K., Spencer, J. F., Dhar, D., Sagartz, J. E., Buller, R. M. L., Painter, G. R., Wold, W. S. M. (2008). Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model. Proc. Natl. Acad. Sci. USA 105: 7293-7297 [Abstract] [Full Text]  
  • Nichols, W. G., Peck Campbell, A. J., Boeckh, M. (2008). Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances. Clin. Microbiol. Rev. 21: 274-290 [Abstract] [Full Text]  
  • Quenelle, D. C., Prichard, M. N., Keith, K. A., Hruby, D. E., Jordan, R., Painter, G. R., Robertson, A., Kern, E. R. (2007). Synergistic Efficacy of the Combination of ST-246 with CMX001 against Orthopoxviruses. Antimicrob. Agents Chemother. 51: 4118-4124 [Abstract] [Full Text]  
  • Quenelle, D. C., Collins, D. J., Herrod, B. P., Keith, K. A., Trahan, J., Beadle, J. R., Hostetler, K. Y., Kern, E. R. (2007). Effect of Oral Treatment with Hexadecyloxypropyl-[(S)-9-(3-Hydroxy-2- Phosphonylmethoxypropyl)Adenine] [(S)-HPMPA] or Octadecyloxyethyl-(S)-HPMPA on Cowpox or Vaccinia Virus Infections in Mice. Antimicrob. Agents Chemother. 51: 3940-3947 [Abstract] [Full Text]  
  • Adams, M. M., Rice, A. D., Moyer, R. W. (2007). Rabbitpox Virus and Vaccinia Virus Infection of Rabbits as a Model for Human Smallpox. J. Virol. 81: 11084-11095 [Abstract] [Full Text]  
  • Painter, G. R., Almond, M. R., Trost, L. C., Lampert, B. M., Neyts, J., De Clercq, E., Korba, B. E., Aldern, K. A., Beadle, J. R., Hostetler, K. Y. (2007). Evaluation of Hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)Propyl]- Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections. Antimicrob. Agents Chemother. 51: 3505-3509 [Abstract] [Full Text]  
  • Lebeau, I., Andrei, G., Krecmerova, M., De Clercq, E., Holy, A., Snoeck, R. (2007). Inhibitory Activities of Three Classes of Acyclic Nucleoside Phosphonates against Murine Polyomavirus and Primate Simian Virus 40 Strains. Antimicrob. Agents Chemother. 51: 2268-2273 [Abstract] [Full Text]  
  • Quenelle, D. C., Buller, R. M. L., Parker, S., Keith, K. A., Hruby, D. E., Jordan, R., Kern, E. R. (2007). Efficacy of Delayed Treatment with ST-246 Given Orally against Systemic Orthopoxvirus Infections in Mice. Antimicrob. Agents Chemother. 51: 689-695 [Abstract] [Full Text]  
  • Choo, H., Beadle, J. R., Kern, E. R., Prichard, M. N., Keith, K. A., Hartline, C. B., Trahan, J., Aldern, K. A., Korba, B. E., Hostetler, K. Y. (2007). Antiviral Activities of Novel 5-Phosphono-Pent-2-en-1-yl Nucleosides and Their Alkoxyalkyl Phosphonoesters. Antimicrob. Agents Chemother. 51: 611-615 [Abstract] [Full Text]  
  • Kornbluth, R. S., Smee, D. F., Sidwell, R. W., Snarsky, V., Evans, D. H., Hostetler, K. Y. (2006). Mutations in the E9L Polymerase Gene of Cidofovir-Resistant Vaccinia Virus Strain WR Are Associated with the Drug Resistance Phenotype. Antimicrob. Agents Chemother. 50: 4038-4043 [Abstract] [Full Text]  
  • Hostetler, K. Y., Aldern, K. A., Wan, W. B., Ciesla, S. L., Beadle, J. R. (2006). Alkoxyalkyl esters of (s)-9-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine are potent inhibitors of the replication of wild-type and drug-resistant human immunodeficiency virus type 1 in vitro.. Antimicrob. Agents Chemother. 50: 2857-2859 [Abstract] [Full Text]  
  • Lebeau, I., Andrei, G., Dal Pozzo, F., Beadle, J. R., Hostetler, K. Y., De Clercq, E., van den Oord, J., Snoeck, R. (2006). Activities of Alkoxyalkyl Esters of Cidofovir (CDV), Cyclic CDV, and (S)-9-(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine against Orthopoxviruses in Cell Monolayers and in Organotypic Cultures.. Antimicrob. Agents Chemother. 50: 2525-2529 [Abstract] [Full Text]  
  • Prichard, M. N., Keith, K. A., Quenelle, D. C., Kern, E. R. (2006). Activity and Mechanism of Action of N-Methanocarbathymidine against Herpesvirus and Orthopoxvirus Infections.. Antimicrob. Agents Chemother. 50: 1336-1341 [Abstract] [Full Text]  
  • Randhawa, P., Farasati, N. A., Shapiro, R., Hostetler, K. Y. (2006). Ether Lipid Ester Derivatives of Cidofovir Inhibit Polyomavirus BK Replication In Vitro.. Antimicrob. Agents Chemother. 50: 1564-1566 [Abstract] [Full Text]  
  • Yang, G., Pevear, D. C., Davies, M. H., Collett, M. S., Bailey, T., Rippen, S., Barone, L., Burns, C., Rhodes, G., Tohan, S., Huggins, J. W., Baker, R. O., Buller, R. L. M., Touchette, E., Waller, K., Schriewer, J., Neyts, J., DeClercq, E., Jones, K., Hruby, D., Jordan, R. (2005). An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge. J. Virol. 79: 13139-13149 [Abstract] [Full Text]  
  • Williams-Aziz, S. L., Hartline, C. B., Harden, E. A., Daily, S. L., Prichard, M. N., Kushner, N. L., Beadle, J. R., Wan, W. B., Hostetler, K. Y., Kern, E. R. (2005). Comparative Activities of Lipid Esters of Cidofovir and Cyclic Cidofovir against Replication of Herpesviruses In Vitro. Antimicrob. Agents Chemother. 49: 3724-3733 [Abstract] [Full Text]  
  • Magee, W. C., Hostetler, K. Y., Evans, D. H. (2005). Mechanism of Inhibition of Vaccinia Virus DNA Polymerase by Cidofovir Diphosphate. Antimicrob. Agents Chemother. 49: 3153-3162 [Abstract] [Full Text]  
  • Wan, W. B., Beadle, J. R., Hartline, C., Kern, E. R., Ciesla, S. L., Valiaeva, N., Hostetler, K. Y. (2005). Comparison of the Antiviral Activities of Alkoxyalkyl and Alkyl Esters of Cidofovir against Human and Murine Cytomegalovirus Replication In Vitro. Antimicrob. Agents Chemother. 49: 656-662 [Abstract] [Full Text]  
  • Kern, E. R., Bidanset, D. J., Hartline, C. B., Yan, Z., Zemlicka, J., Quenelle, D. C. (2004). Oral Activity of a Methylenecyclopropane Analog, Cyclopropavir, in Animal Models for Cytomegalovirus Infections. Antimicrob. Agents Chemother. 48: 4745-4753 [Abstract] [Full Text]  
  • Kern, E. R., Collins, D. J., Wan, W. B., Beadle, J. R., Hostetler, K. Y., Quenelle, D. C. (2004). Oral Treatment of Murine Cytomegalovirus Infections with Ether Lipid Esters of Cidofovir. Antimicrob. Agents Chemother. 48: 3516-3522 [Abstract] [Full Text]  
  • Bray, M., Roy, C. J. (2004). Antiviral prophylaxis of smallpox. J Antimicrob Chemother 54: 1-5 [Abstract] [Full Text]  
  • Keith, K. A., Wan, W. B., Ciesla, S. L., Beadle, J. R., Hostetler, K. Y., Kern, E. R. (2004). Inhibitory Activity of Alkoxyalkyl and Alkyl Esters of Cidofovir and Cyclic Cidofovir against Orthopoxvirus Replication In Vitro. Antimicrob. Agents Chemother. 48: 1869-1871 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»